Section 125.221

14 CFR Ch. I (1-1-19 Edition)

including a description of the deviation
and the reasons for it.
(f) Portable oxygen concentrators - (1)
Acceptance criteria. A passenger may
carry or operate a portable oxygen concentrator for personal use on board an
aircraft and a certificate holder may
allow a passenger to carry or operate a
portable oxygen concentrator on board
an aircraft operated under this part
during all phases of flight if the portable oxygen concentrator satisfies all
of the requirements in this paragraph
(f):
(i) Is legally marketed in the United
States in accordance with Food and
Drug Administration requirements in
title 21 of the CFR;
(ii) Does not radiate radio frequency
emissions that interfere with aircraft
systems;
(iii) Generates a maximum oxygen
pressure of less than 200 kPa gauge
(29.0 psig/43.8 psia) at 20 SectionC (68 SectionF);
(iv) Does not contain any hazardous
materials subject to the Hazardous Materials Regulations (49 CFR parts 171
through 180) except as provided in 49
CFR 175.10 for batteries used to power
portable electronic devices and that do
not require aircraft operator approval;
and
(v) Bears a label on the exterior of
the device applied in a manner that ensures the label will remain affixed for
the life of the device and containing
the following certification statement
in red lettering:  - The manufacturer of
this POC has determined this device
conforms to all applicable FAA acceptance criteria for POC carriage and use
on board aircraft. -  The label requirements in this paragraph (f)(1)(v) do not
apply to the following portable oxygen
concentrators approved by the FAA for
use on board aircraft prior to May 24,
2016:
(A) AirSep Focus;
(B) AirSep FreeStyle;
(C) AirSep FreeStyle 5;
(D) AirSep LifeStyle;
(E) Delphi RS-00400;
(F) DeVilbiss Healthcare iGo;
(G) Inogen One;
(H) Inogen One G2;
(I) Inogen One G3;
(J) Inova Labs LifeChoice;

(K) Inova Labs LifeChoice Activox;
(L)
International
Biophysics
LifeChoice;
(M) Invacare Solo2;
(N) Invacare XPO2;
(O) Oxlife Independence Oxygen Concentrator;
(P) Oxus RS-00400;
(Q) Precision Medical EasyPulse;
(R) Respironics EverGo;
(S) Respironics SimplyGo;
(T) SeQual Eclipse;
(U) SeQual eQuinox Oxygen System
(model 4000);
(V) SeQual Oxywell Oxygen System
(model 4000);
(W) SeQual SAROS; and
(X) VBox Trooper Oxygen Concentrator.
(2) Operating requirements. Portable
oxygen concentrators that satisfy the
acceptance criteria identified in paragraph (f)(1) of this section may be carried or used by a passenger on an aircraft provided the aircraft operator ensures that all of the conditions in this
paragraph (f)(2) are satisfied:
(i) Exit seats. No person operating a
portable oxygen concentrator is permitted to occupy an exit seat.
(ii) Stowage of device. During movement on the surface, takeoff and landing, the device must be stowed under
the seat in front of the user, or in another approved stowage location so
that it does not block the aisle way or
the entryway to the row. If the device
is to be operated by the user, it must
be operated only at a seat location that
does not restrict any passenger-s access
to, or use of, any required emergency
or regular exit, or the aisle(s) in the
passenger compartment.
[Docket No. 19779, 45 FR 67235, Oct. 9, 1980, as
amended by Docket FAA-2014-0554, Amdt.
125-65, 81 FR 33119, May 24, 2016; Docket
FAA-2018-0119, Amdt. 125-68, 83 FR 9173, Mar.
5, 2018]

Section 125.221 Icing conditions: Operating
limitations.
(a) No pilot may take off an airplane
that has frost, ice, or snow adhering to
any propeller, windshield, stabilizing
or control surface; to a powerplant installation; or to an airspeed, altimeter,

336

VerDate Sep<11>2014

08:20 May 17, 2019

Jkt 247048

PO 00000

Frm 00346

Fmt 8010

Sfmt 8002

Y:\SGML\247048.XXX

247048